Skip to main content

Our commercial and scientific collaborations 


SphingoTec is collaborating with leading hospitals in Europe, the US and a growing network of key opinion leaders in the field of acute care medicine. In collaboration with our network we develop fundamental solutions for fighting mortality in critical care settings.

Learn more

Clinical Evaluation

With the mission of improving patient management in critical care settings, SphingoTec has started a series of collaboration with internationally leading academic and non-academic medical centers. The main goal of these collaborations is to implement tests for novel biomarkers in the clinical routine and hence translate science into medical practice.

Learn more

Distribution Partners

SphingoTec has an international qualified network of distribution partners with which we work in close cooperation and mutual support. We are committed to providing our partners with exceptional levels of service and we are actively building long-term global relationships. 

Learn more

Biomarker out-licensing

SphingoTec has established an extended intellectual property portfolio covering markers for acute care conditions such as sepsis, acute heart failure and acute kidney injury. All biomarkers are available for licensing to companies wishing to develop assays for clinical use on their immunoassay platforms.

Learn more